Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $174.74 | 2 | 91.1% |
| Food and Beverage | $17.04 | 1 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $174.74 | 2 | $0 (2023) |
| LEO Pharma Inc. | $17.04 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $94.99 | 1 | Janssen Biotech, Inc. ($94.99) |
| 2021 | $79.75 | 1 | Janssen Biotech, Inc. ($79.75) |
| 2017 | $17.04 | 1 | LEO Pharma Inc. ($17.04) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 04/15/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA, SIMPONI ARIA | Education | In-kind items and services | $79.75 | General |
| Category: Immunology | ||||||
| 04/11/2017 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,723 | 21,238 | $534,847 | $159,072 |
| 2022 | 17 | 1,807 | 24,138 | $550,830 | $166,401 |
| 2021 | 19 | 1,829 | 23,528 | $461,069 | $143,902 |
| 2020 | 21 | 1,758 | 17,122 | $432,067 | $121,568 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 436 | 666 | $107,543 | $39,021 | 36.3% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 60 | 17,200 | $57,104 | $21,497 | 37.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 19 | 61 | $49,410 | $18,195 | 36.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 335 | 462 | $81,945 | $16,597 | 20.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 129 | 151 | $36,370 | $10,828 | 29.8% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 72 | 116 | $31,816 | $10,676 | 33.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 138 | 171 | $52,668 | $10,214 | 19.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 270 | 1,794 | $32,202 | $8,611 | 26.7% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 37 | 334 | $21,710 | $5,530 | 25.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 30 | 36 | $13,895 | $4,115 | 29.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 62 | $10,298 | $2,393 | 23.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $7,421 | $2,216 | 29.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 52 | $5,876 | $1,890 | 32.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 17 | $6,542 | $1,736 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 19 | $4,406 | $1,671 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,550 | $1,128 | 31.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $4,259 | $1,063 | 25.0% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 15 | $4,749 | $993.00 | 20.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 24 | $2,974 | $682.00 | 22.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 21 | $107.73 | $15.44 | 14.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 461 | 696 | $106,841 | $40,940 | 38.3% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2022 | 71 | 20,000 | $66,400 | $24,175 | 36.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 17 | 66 | $53,460 | $19,553 | 36.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 355 | 515 | $91,346 | $18,501 | 20.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 163 | 202 | $62,216 | $12,941 | 20.8% |
About Dr. C Hansen, M.D
Dr. C Hansen, M.D is a Procedural Dermatology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548366743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. C Hansen, M.D has received a total of $191.78 in payments from pharmaceutical and medical device companies, with $94.99 received in 2023. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Education" ($174.74).
As a Medicare-enrolled provider, Hansen has provided services to 7,117 Medicare beneficiaries, totaling 86,026 services with total Medicare billing of $590,944. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Dermatology, Dermatopathology
- Location Salt Lake City, UT
- Active Since 09/15/2006
- Last Updated 11/02/2021
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1548366743
Products in Payments
- TREMFYA (Drug) $174.74
- ENSTILAR (Drug) $17.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Procedural Dermatology Doctors in Salt Lake City
Dr. Gerald Krueger, M.d, M.D
Procedural Dermatology — Payments: $448,256
Dr. Elena Hadjicharalambous, Md, MD
Procedural Dermatology — Payments: $7,979
Dr. Douglas Powell, M.d, M.D
Procedural Dermatology — Payments: $2,541
Dr. Christopher Hull, M.d, M.D
Procedural Dermatology — Payments: $285.63
Dr. Marta Petersen, M.d, M.D
Procedural Dermatology — Payments: $250.00
Dr. Douglas Grossman, M.d, M.D
Procedural Dermatology — Payments: $31.52